MetaADEDB 2.0 @ LMMD
edoxaban
(HGVDHZBSSITLCT-JLJPHGGASA-N)
Structure
SMILES
CN1CCc2c(C1)sc(n2)C(=O)N[C@@H]1C[C@H](CC[C@@H]1NC(=O)C(=O)Nc1ccc(cn1)Cl)C(=O)N(C)C
Type(s)
Approved
ATC code(s)
B01AF03
Molecular Formula:
C24H30ClN7O4S
Molecular Weight:
548.058
Log P:
2.0823
Hydrogen Bond Acceptor:
12
Hydrogen Bond Donor:
3
TPSA:
164.87
CAS Number(s):
480449-70-5; 912273-65-5
Synonym(s)
1.
edoxaban
2.
DU-176
3.
DU-176b
4.
N-(5-chloropyridin-2-yl)-N'-((1S,2R,4S)-4-(N,N-dimethylcarbamoyl)-2-(5-methyl-4,5,6,7- tetrahydro(1,3)thiazolo(5,4-c)pyridine-2-carboxamido)cyclohexyl)oxamide
5.
N-(5-chloropyridin-2-yl)-N'-((1S,2R,4S)-4-(N,N-dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo(5,4-c)pyridine-2-carboxamido)cyclohexyl)ethanediamide p-toluenesulfonate monohydrate
6.
edoxaban tosylate
External Link(s)
MeSHC552171
PubChem Compound10280735
BindingDB50328731
ChEBI85973
CHEMBLCHEMBL1269025
DrugBankDB09075
DrugCentral4897
IUPHAR/BPS Guide to PHARMACOLOGY7575
KEGGdr:D09546
dr:D09710
Therapeutic Target DatabaseD0C3BS
ZINC43200832
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Cerebrovascular accidentFAERS: 110
Canada Vigilance: 1
Canada Vigilance
US FAERS
2Cerebral InfarctionFAERS: 92US FAERS
3Embolic strokeFAERS: 43US FAERS
4Pulmonary EmbolismFAERS: 42US FAERS
5EpistaxisFAERS: 41US FAERS
6NauseaFAERS: 35US FAERS
7DizzinessFAERS: 28US FAERS
8ThrombosisFAERS: 25US FAERS
9HeadacheFAERS: 23US FAERS
10Deep Vein ThrombosisFAERS: 22US FAERS
11Incorrect dose administeredFAERS: 18US FAERS
12FatigueFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
13PneumoniaFAERS: 16US FAERS
14No adverse eventFAERS: 15US FAERS
15VomitingFAERS: 15US FAERS
16Abdominal discomfortFAERS: 14US FAERS
17PruritusFAERS: 14US FAERS
18Atrial thrombosisFAERS: 13US FAERS
19Chest PainFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
20Blood urine presentFAERS: 11US FAERS
21AstheniaFAERS: 9US FAERS
22ArthralgiaFAERS: 8US FAERS
23MalaiseFAERS: 8US FAERS
24Drug administration errorFAERS: 7US FAERS
25Drug ineffectiveFAERS: 7US FAERS
26EmbolismFAERS: 7US FAERS
27Gastric ulcerFAERS: 7US FAERS
28MyalgiaFAERS: 7US FAERS
29PainFAERS: 7US FAERS
30Peripheral swellingFAERS: 7US FAERS
31Abdominal PainFAERS: 6US FAERS
32AphasiaFAERS: 6US FAERS
33Atrial FibrillationFAERS: 6US FAERS
34HemiparesisFAERS: 6US FAERS
35Sudden deathFAERS: 6US FAERS
36Unevaluable eventFAERS: 6US FAERS
37UrticariaFAERS: 6US FAERS
38Visual ImpairmentFAERS: 6US FAERS
39Acute kidney injuryFAERS: 5US FAERS
40Back PainFAERS: 5US FAERS
41Cerebral artery occlusionFAERS: 5US FAERS
42DiplopiaFAERS: 5US FAERS
43Disseminated Intravascular CoagulationFAERS: 5US FAERS
44Drug dose omissionFAERS: 5US FAERS
45GastrostomyFAERS: 5US FAERS
46OverdoseFAERS: 5US FAERS
47Weight decreasedFAERS: 5US FAERS
48AlopeciaFAERS: 4US FAERS
49ChromaturiaFAERS: 4US FAERS
50DeliriumFAERS: 4US FAERS
51DyspepsiaFAERS: 4US FAERS
52Embolic cerebral infarctionFAERS: 4US FAERS
53FractureFAERS: 4US FAERS
54HypersensitivityFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
55IleusFAERS: 4US FAERS
56Product dose omissionFAERS: 4US FAERS
57SepsisFAERS: 4US FAERS
58SyncopeFAERS: 4US FAERS
59ThrombocytopeniaFAERS: 4US FAERS
60Thrombotic cerebral infarctionFAERS: 4US FAERS
61TinnitusFAERS: 4US FAERS
62Urinary tract infectionFAERS: 4US FAERS
63Cardiac ArrestFAERS: 3US FAERS
64Cardiac TamponadeFAERS: 3US FAERS
65Creatinine renal clearance decreasedFAERS: 3US FAERS
66DementiaFAERS: 3US FAERS
67Duodenal UlcerFAERS: 3US FAERS
68DysarthriaFAERS: 3US FAERS
69EpilepsyFAERS: 3US FAERS
70GastritisFAERS: 3US FAERS
71HemiplegiaFAERS: 3US FAERS
72Hip surgeryFAERS: 3US FAERS
73HypotensionFAERS: 3US FAERS
74InfectionFAERS: 3US FAERS
75LacerationFAERS: 3US FAERS
76Maternal exposure during pregnancyFAERS: 3US FAERS
77Medication ErrorFAERS: 3US FAERS
78Memory impairmentFAERS: 3US FAERS
79Myocardial InfarctionFAERS: 3US FAERS
80PalpitationsFAERS: 3US FAERS
81PetechiaeFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
82Respiratory FailureFAERS: 3US FAERS
83StomatitisFAERS: 3US FAERS
84Therapeutic response unexpectedFAERS: 3US FAERS
85UlcerFAERS: 3US FAERS
86Urinary RetentionFAERS: 3US FAERS
87Uterine CancerFAERS: 3US FAERS
88VasculitisFAERS: 3US FAERS
89VertigoFAERS: 3US FAERS
90White blood cell count decreasedFAERS: 3US FAERS
91AmnesiaFAERS: 2US FAERS
92Angina PectorisFAERS: 2US FAERS
93AngioedemaFAERS: 2US FAERS
94Arterial thrombosisFAERS: 2US FAERS
95ArthritisFAERS: 2US FAERS
96ArthropathyFAERS: 2US FAERS
97AsthmaFAERS: 2US FAERS
98Blood glucose increasedFAERS: 2US FAERS
99Blood triglycerides increasedFAERS: 2US FAERS
100BradycardiaFAERS: 2US FAERS
101BronchitisFAERS: 2US FAERS
102Cardiac ablationFAERS: 2US FAERS
103Carotid artery occlusionFAERS: 2US FAERS
104Cerebral ventricular ruptureFAERS: 2US FAERS
105CholecystitisFAERS: 2US FAERS
106CholestasisFAERS: 2US FAERS
107Compression fractureFAERS: 2US FAERS
108ConstipationFAERS: 2US FAERS
109Creatinine renal clearance increasedFAERS: 2US FAERS
110DeafnessFAERS: 2US FAERS
111DehydrationFAERS: 2US FAERS
112Drug prescribing errorFAERS: 2US FAERS
113DysgeusiaFAERS: 2US FAERS
114EczemaFAERS: 2US FAERS
115Feeling ColdFAERS: 2US FAERS
116Fibrin D dimer increasedFAERS: 2US FAERS
117Gamma-Glutamyltransferase IncreasedFAERS: 2US FAERS
118HerniaFAERS: 2US FAERS
119Hypertensive crisisFAERS: 2US FAERS
120Inappropriate schedule of drug administrationFAERS: 2US FAERS
121Inappropriate schedule of product administrationFAERS: 2US FAERS
122Increased tendency to bruiseFAERS: 2US FAERS
123Joint swellingFAERS: 2US FAERS
124Macular degenerationFAERS: 2US FAERS
125Medication residue presentFAERS: 2US FAERS
126MenorrhagiaFAERS: 2US FAERS
127Muscle tightnessFAERS: 2US FAERS
128Musculoskeletal PainFAERS: 2US FAERS
129NasopharyngitisFAERS: 2US FAERS
130NephrolithiasisFAERS: 2US FAERS
131PallorFAERS: 2US FAERS
132ParanoiaFAERS: 2US FAERS
133ParesisFAERS: 2US FAERS
134Product administered to patient of inappropriate ageFAERS: 2US FAERS
135Product administration errorFAERS: 2US FAERS
136StridorFAERS: 2US FAERS
137TachycardiaFAERS: 2US FAERS
138Therapy non-responderFAERS: 2US FAERS
139Uterine myoma expulsionFAERS: 2US FAERS
140cancer surgeryFAERS: 2US FAERS
141AbasiaFAERS: 1US FAERS
142Acute myocardial infarctionFAERS: 1US FAERS
143Acute respiratory failureFAERS: 1US FAERS
144Adverse eventFAERS: 1US FAERS
145AgranulocytosisFAERS: 1US FAERS
146Alanine Aminotransferase IncreasedFAERS: 1US FAERS
147Alanine aminotransferase abnormalFAERS: 1US FAERS
148Amaurosis FugaxFAERS: 1US FAERS
149Antiphospholipid SyndromeFAERS: 1US FAERS
150Aortic Valve StenosisFAERS: 1US FAERS
151AscitesFAERS: 1US FAERS
152Aspartate aminotransferase abnormalFAERS: 1US FAERS
153Atrial FlutterFAERS: 1US FAERS
154Back disorderFAERS: 1US FAERS
155Benign Prostatic HyperplasiaFAERS: 1US FAERS
156Blood alkaline phosphatase increasedFAERS: 1US FAERS
157Blood blisterFAERS: 1US FAERS
158Blood count abnormalFAERS: 1US FAERS
159Blood creatinine increasedFAERS: 1US FAERS
160Blood iron decreasedFAERS: 1US FAERS
161Blood sodium increasedFAERS: 1US FAERS
162Bone painFAERS: 1US FAERS
163Bowen's DiseaseFAERS: 1US FAERS
164Burning sensationFAERS: 1US FAERS
165BursitisFAERS: 1US FAERS
166Capillary FragilityFAERS: 1US FAERS
167Cardiac DeathFAERS: 1US FAERS
168Cardiac dysfunctionFAERS: 1US FAERS
169Cardiac ventricular thrombosisFAERS: 1US FAERS
170Carotid Artery ThrombosisFAERS: 1US FAERS
171Carpal Tunnel SyndromeFAERS: 1US FAERS
172CataractFAERS: 1US FAERS
173CatarrhFAERS: 1US FAERS
174Catheter site thrombosisFAERS: 1US FAERS
175CellulitisFAERS: 1US FAERS
176Cerebellar infarctionFAERS: 1US FAERS
177Cerebral ThrombosisFAERS: 1US FAERS
178Chest discomfortFAERS: 1US FAERS
179Choking sensationFAERS: 1US FAERS
180CholangiocarcinomaFAERS: 1US FAERS
181ColitisFAERS: 1US FAERS
182Coronary angioplastyFAERS: 1US FAERS
183CyanopsiaFAERS: 1US FAERS
184Depressed Level of ConsciousnessFAERS: 1US FAERS
185Diabetes InsipidusFAERS: 1US FAERS
186Diabetes MellitusFAERS: 1US FAERS
187Drug dispensing errorFAERS: 1US FAERS
188Drug ineffective for unapproved indicationFAERS: 1US FAERS
189Drug level below therapeuticFAERS: 1US FAERS
190Drug resistanceFAERS: 1US FAERS
191Duodenal ObstructionFAERS: 1US FAERS
192Ear canal injuryFAERS: 1US FAERS
193Ejection Fraction DecreasedFAERS: 1US FAERS
194Emotional distressFAERS: 1US FAERS
195EosinophiliaFAERS: 1US FAERS
196Exposure via body fluidFAERS: 1US FAERS
197Eye painFAERS: 1US FAERS
198Facial NeuralgiaFAERS: 1US FAERS
199Facial paralysisFAERS: 1US FAERS
200Factor VIII DeficiencyFAERS: 1US FAERS
201Feeling jitteryFAERS: 1US FAERS
202Feeling of body temperature changeFAERS: 1US FAERS
203FlatulenceFAERS: 1US FAERS
204Gaze palsyFAERS: 1US FAERS
205General physical health deteriorationFAERS: 1US FAERS
206Genitourinary operationFAERS: 1US FAERS
207GoutFAERS: 1US FAERS
208Hepatitis CFAERS: 1US FAERS
209HepatitisFAERS: 1US FAERS
210HydrocephalusFAERS: 1US FAERS
211HypersomniaFAERS: 1US FAERS
212HypertransaminasaemiaFAERS: 1US FAERS
213HyperventilationFAERS: 1US FAERS
214Immune thrombocytopenic purpuraFAERS: 1US FAERS
215IncontinenceFAERS: 1US FAERS
216Intestinal PerforationFAERS: 1US FAERS
217IntussusceptionFAERS: 1US FAERS
218Joint stiffnessFAERS: 1US FAERS
219Kidney ablationFAERS: 1US FAERS
220LaparotomyFAERS: 1US FAERS
221Large intestine erosionFAERS: 1US FAERS
222LethargyFAERS: 1US FAERS
223LeukocytosisFAERS: 1US FAERS
224Limb operationFAERS: 1US FAERS
225Lip swellingFAERS: 1US FAERS
226Liver AbscessFAERS: 1US FAERS
227Lower respiratory tract infectionFAERS: 1US FAERS
228Malignant neoplasm progressionFAERS: 1US FAERS
229Mallory-Weiss SyndromeFAERS: 1US FAERS
230MarasmusFAERS: 1US FAERS
231MetrorrhagiaFAERS: 1US FAERS
232MonoparesisFAERS: 1US FAERS
233MonoplegiaFAERS: 1US FAERS
234Muscle FatigueFAERS: 1US FAERS
235MyomectomyFAERS: 1US FAERS
236Neck PainFAERS: 1US FAERS
237NeutropeniaFAERS: 1US FAERS
238Occult blood positiveFAERS: 1US FAERS
239OverweightFAERS: 1US FAERS
240PancytopeniaFAERS: 1US FAERS
241PapuleFAERS: 1US FAERS
242ParacentesisFAERS: 1US FAERS
243Pelvic venous thrombosisFAERS: 1US FAERS
244Penile size reducedFAERS: 1US FAERS
245Periorbital disorderFAERS: 1US FAERS
246Poor quality sleepFAERS: 1US FAERS
247Portal Vein ThrombosisFAERS: 1US FAERS
248Post procedural persistent drain fluidFAERS: 1US FAERS
249Prerenal failureFAERS: 1US FAERS
250Prescribed underdoseFAERS: 1US FAERS
251Pulmonary amyloidosisFAERS: 1US FAERS
252PurpuraFAERS: 1US FAERS
253PyelonephritisFAERS: 1US FAERS
254PyuriaFAERS: 1US FAERS
255Rash erythematousFAERS: 1US FAERS
256Reaction to drug excipientsFAERS: 1US FAERS
257Rebound effectFAERS: 1US FAERS
258Renal embolismFAERS: 1US FAERS
259Renal painFAERS: 1US FAERS
260RestlessnessFAERS: 1US FAERS
261Retinal Artery OcclusionFAERS: 1US FAERS
262Rheumatoid ArthritisFAERS: 1US FAERS
263Septic ShockFAERS: 1US FAERS
264Skin UlcerFAERS: 1US FAERS
265Skin reactionFAERS: 1US FAERS
266SomnolenceFAERS: 1US FAERS
267Splenic RuptureFAERS: 1US FAERS
268Stent patency maintenanceFAERS: 1US FAERS
269StillbirthFAERS: 1US FAERS
270StressFAERS: 1US FAERS
271Sudden Cardiac DeathFAERS: 1US FAERS
272SwellingFAERS: 1US FAERS
273Thalamic infarctionFAERS: 1US FAERS
274Throat irritationFAERS: 1US FAERS
275Thrombotic strokeFAERS: 1US FAERS
276Trousseau's syndromeFAERS: 1US FAERS
277Vascular stent thrombosisFAERS: 1US FAERS
278Venous thrombosis limbFAERS: 1US FAERS
279Vitreous floatersFAERS: 1US FAERS
280colonoscopyFAERS: 1US FAERS
281jaundiceFAERS: 1US FAERS
282treatment failureFAERS: 1US FAERS
283Hemorrhage28689179CTD
284Product substitution issueCanada Vigilance: 1Canada Vigilance
285Venous Thromboembolism28689179CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.